Novartis Pharmaceuticals Corporation vs. The Regents of the University of Michigan et al.
Explore the PTAB proceeding IPR2023-01347 filed by Novartis Pharmaceuticals Corporation on 2023-08-28. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-01347
Filing Date
2023-08-28
Accorded Filing Date
2023-08-28
Institution Decision Date
2024-03-13
Last Modified Date
2025-04-29
Proceeding Type
IPR
Termination Date
2024-08-28
Trial Status
Terminated-Adverse Judgment
Parties & Counsel
Petitioner
Novartis Pharmaceuticals Corporation
Represented By
Kallas, Nicholaset alPatent Owner / Respondent
Tribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Respondent Application Number
14179862
Respondent Patent Number
10633344
External Links
Respondent Inventor
Michael J. Zaworotko et al
Respondent Tech Center
TC 1600 - Biotechnology & Organic Chemistry
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Firm
/ Entity Name
WOLF GREENFIELD & SACKS, P.C.
Customer
Number
23628
Address
600 ATLANTIC AVENUE, BOSTON, MA, 02210-2206, UNITED STATES
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 28129 | John Welch | 617-646-8000 |
| 31616 | Edward Gates | 617-646-8000 |
| 31624 | Jason Honeyman | 617-646-8222 |
| 32950 | Edmund Walsh | 617-646-8000 |
| 34681 | James Morris | 617-646-8000 |
| 35986 | Randy Pritzker | 617-646-8000 |
| 36149 | Richard Giunta | 617-646-8000 |
| 36628 | Timothy Oyer | 617-646-8251 |
Proceeding Documents
135
23
Order: Setting Oral Argument 37 C.F.R. sec. 42.70 ORDER
2024-12-11
FILING PARTY: BOARD
22
Adverse judgment: post-institution ADVRSJUDG
2024-08-28
FILING PARTY: BOARD
1591
Ex. 1591 - July 31, 2024 Board E-mail Exhibit
2024-08-06
FILING PARTY: PETITIONER
None
Motion for Adverse Judgment MOTION
2024-08-06
FILING PARTY: PETITIONER
20
Motion for Adverse Judgment MOTION
2024-08-06
FILING PARTY: PETITIONER